(S)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol

Catalog No. :
ACGZKY651
CAS No. :
1221187-74-1
Molecular Formula :
C6H8N2O
Molecular Weight :
124.14

IUPAC Name:(S)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol

(S)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$116.00Login to see priceIn stockInquiry
250mg97%$214.00Login to see priceIn stockInquiry
1g97%$533.00Login to see priceIn stockInquiry
5g97%$1784.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol
IUPAC Name(S)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol
MDL No.MFCD31801296
Molecular FormulaC6H8N2O
Molecular Weight124.14
SMILESO[C@H]1CCN2C=CN=C21
InChI KeyZNTOIYUPLXOHAS-YFKPBYRVSA-N
SynonymCS-0135854 | MFCD31801296 | (7S)-5H,6H,7H-pyrrolo[1,2-a]imidazol-7-ol | (7S)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol | AT24599 | (S)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol | 1221187-74-1 | 5H-Pyrrolo[1,2-a]imidazol-7-ol, 6,7-dihydro-, (7S)- | SCHEM
CAS No.1221187-74-1
PubChem CID92977143

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGZKY651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBHAL749 route compound structure diagram
    ACBHAL749112513-82-3 In Stock
  2. Then
  3. ACGZKY651 route product structure diagram
    ACGZKY6511221187-74-1 In Stock
Inquiry

2. ACGZKY651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZKY651 route product structure diagram
    ACGZKY6511221187-74-1 In Stock
Inquiry

Comments (0)